Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

Study ID: NCT06420167
Start Date: 2024-07-11
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Dapagliflozin

Sponsor

Barbara Ann Karmanos Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

Study ID: NCT05736367
Start Date: 2024-11-15
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

U-13C-glucose

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Study ID: NCT05837767
Start Date: 2023-07-24
End Date: 2026-07-24
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

26

Intervention / Treatment

Stereotactic body radiotherapy

Lattice Radiation Therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

Study ID: NCT05328167
Start Date: 2021-12-14
End Date: 2025-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Perflutren Protein-Type A Microspheres

Contrast-Enhanced Ultrasound

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Study ID: NCT04628767
Start Date: 2021-11-12
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

249

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Cisplatin

Computed Tomography

Doxorubicin Hydrochloride

Durvalumab

Gemcitabine Hydrochloride

Magnetic Resonance Imaging

Methotrexate

Freak

Therapeutic Conventional Surgery

Vinblastine Sulfate

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Metformin and Nightly Fasting in Women With Early Breast Cancer

Study ID: NCT05023967
Start Date: 2023-04-04
End Date: 2025-11-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Biospecimen Collection

Extended Release Metformin Hydrochloride

Monitoring

Nutritional Assessment

Short-Term Fasting

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

Study ID: NCT06402201
Start Date: 2024-05-24
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

42

Intervention / Treatment

CDR404

Sponsor

CDR-Life AG

Source: clinicaltrials.gov

Share:
Add to list

ETHAN - ET for Male BC

Study ID: NCT05501704
Start Date: 2023-10-11
End Date: 2036-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Ta grinding powder

Anastrozole

Degarelix

Abemaciclib

Sponsor

Jose Pablo Leone

Source: clinicaltrials.gov

Share:
Add to list

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Study ID: NCT06589440
Start Date: 2024-11-20
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Sr-8541a

Sponsor

Stingray Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies

Study ID: NCT04404101
Start Date: 2021-05-11
End Date: 2025-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

1). EUS-FNA PLUS MFB

2). EUS-FNA Alone

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list